Gilead Brings In Sanofi’s Dietmar Berger To Reset Drug Development

 
• By Andrew McConaghie

The oncology drug development veteran has been hired by former colleague Daniel O’Day as Gilead looks to improve its R&D hit rate.

Gilead
Gilead adds in liver with CymaBay acquisition • Source: Shutterstock: Tada Images

More from Executives On The Move

More from Scrip